Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SEATTLE GENETICS INC Financial Overview

  • Income Statement: SGEN
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 35.24 M 22.42 M 12.82 M 36.37%
    Gross Profit 31.82 M 19.87 M 11.95 M 37.55%
    Net Income Before Extra Items/Preferred Div -85.50 M -48.93 M -36.57 M 42.77%
    Operating Income -91.79 M -55.64 M -36.14 M 39.38%
    View Full Report

  • Cash Flow: SGEN
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 101.61 M 6.60 M 95.01 M 93.50%
    Net Cash Flow - Investing 67.83 M -4.07 M 71.90 M 106.00%
    Net Cash Flow/Operating Activities -62.63 M 39.83 M -102.46 M 163.60%
    View Full Report

  • Balance Sheet: SGEN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 187.72 M 148.53 M 39.19 M 20.88%
    Total Liabilities 108.70 M 94.54 M 14.16 M 13.02%
    Shareholders Equity 79.02 M 53.99 M 25.03 M 31.68%
    View Full Report

  • Key Ratios / Statistics: SGEN

    • Valuation

      Price/Earnings (TTM) -8.20
      Price/Sales (TTM) 19.97
      Price/Book (MRQ) 8.44
      Price/Cash Flow (TTM) -10.09

    • Profitability

      Gross Margin 90.31
      Operating Margin -260.49
      Profit Margin -242.65

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 2.62
      Current Ratio (MRQ) 13.94
      Long Term Debt-to-Equity (MRQ) 0.00

    • Management Effectiveness

      Return on Equity (TTM) -121.80
      Return on Assets (TTM) -37.07
      Return on Investments (TTM) -128.57
    View All Key Ratios